Skip to content
healthcare.dev

Gabapentin

NDC 50228-180, Gabapentin, capsule, from ScieGen Pharmaceuticals, Inc..

Product NDC
50228-180
Status
Listed
Labeler
ScieGen Pharmaceuticals, Inc.
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA204989
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/50228-180 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GABAPENTIN300 mg/1

Pharmacologic classes

Decreased Central Nervous System Disorganized Electrical Activity [PE]

Package NDCNDC-11Package
50228-180-0150228018001100 CAPSULE in 1 BOTTLE, PLASTIC (50228-180-01)
50228-180-0550228018005500 CAPSULE in 1 BOTTLE, PLASTIC (50228-180-05)
50228-180-10502280180101000 CAPSULE in 1 BOTTLE, PLASTIC (50228-180-10)
50228-180-305022801803030 CAPSULE in 1 BOTTLE, PLASTIC (50228-180-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/16542ee6-0e0e-4d3c-8b32-60ff6ef48846
  • NADAC price for package 50228018001

    GET /v1/drugs/nadac/50228018001
  • NADAC price for package 50228018005

    GET /v1/drugs/nadac/50228018005
  • NADAC price for package 50228018010

    GET /v1/drugs/nadac/50228018010

Use it

Look up 50228-180 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/50228-180 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 50228-180. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.